Oncotarget
H&E of the wild type Pten+/- gallbladders. See Lunardi et al.
Ribosomal proteins as unrevealed caretakers for cellular stress and genomic instability |
https://doi.org/10.18632/oncotarget.1784 Tae-Hyung Kim, Patrick Leslie, and Yanping Zhang |
860-871 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
miR-34: from bench to bedside |
https://doi.org/10.18632/oncotarget.1825 Massimiliano Agostini, and Richard A. Knight |
872-881 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Genome-wide shRNA screen revealed integrated mitogenic signaling between dopamine receptor D2 (DRD2) and epidermal growth factor receptor (EGFR) in glioblastoma |
https://doi.org/10.18632/oncotarget.1801 Jie Li, Shan Zhu, David Kozono, Kimberly Ng, Diahnn Futalan, Ying Shen, Johnny C. Akers, Tyler Steed, Deepa Kushwaha, Michael Schlabach, Bob S. Carter, Chang-Hyuk Kwon, Frank Furnari, Webster Cavenee, Stephen Elledge, and Clark C. Chen |
882-893 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Role of aberrant PI3K pathway activation in gallbladder tumorigenesis |
https://doi.org/10.18632/oncotarget.1808 Andrea Lunardi, Kaitlyn A. Webster, Antonella Papa, Bhavik Padmani, John G. Clohessy, Roderick T. Bronson, and Pier Paolo Pandolfi |
894-900 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
A novel peptide that inhibits E2F transcription and regresses prostate tumor xenografts |
https://doi.org/10.18632/oncotarget.1809 Xiaoqi Xie, Nitu Bansal, Tazeem Shaik, John E. Kerrigan, Tamara Minko, Olga Garbuzenko, Emine Ercikan Abali, Nadine Johnson-Farley, Debabrata Banerjee, Kathleen W. Scotto, and Joseph R. Bertino |
901-907 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
A potential therapeutic strategy for chronic lymphocytic leukemia by combining Idelalisib and GS-9973, a novel spleen tyrosine kinase (Syk) inhibitor |
https://doi.org/10.18632/oncotarget.1484 Russell T Burke, Marc M Loriaux, Kevin S Currie, Scott A Mitchell, Patricia Maciejewski, Astrid S Clarke, Julie A DiPaolo, Brian J Druker, Stephen E Spurgeon, and Brian J Lannutti |
908-915 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Clinical impact of gene mutations and lesions detected by SNP-array karyotyping in acute myeloid leukemia patients in the context of gemtuzumab ozogamicin treatment: Results of the ALFA-0701 trial |
https://doi.org/10.18632/oncotarget.1536 Aline Renneville, Raouf Ben Abdelali, Sylvie Chevret, Olivier Nibourel, Meyling Cheok, Cecile Pautas, Remy Dulery, Thomas Boyer, Jean-Michel Cayuela, Sandrine Hayette, Emmanuel Raffoux, Hassan Farhat, Nicolas Boissel, Christine Terre, Herve Dombret, Sylvie Castaigne, and Claude Preudhomme |
916-932 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
High Mdm4 levels suppress p53 activity and enhance its half-life in acute myeloid leukaemia |
https://doi.org/10.18632/oncotarget.1559 Ban Xiong Tan, Kian Hoe Khoo, Tit Meng Lim, and David Philip Lane |
933-943 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Epigenetic silencing of microRNA-199b-5p is associated with acquired chemoresistance via activation of JAG1-Notch1 signaling in ovarian cancer |
https://doi.org/10.18632/oncotarget.1458 Michelle X. Liu, Michelle KY. Siu, Stephanie S. Liu, Judy WP. Yam, Hextan YS. Ngan, and David W. Chan |
944-958 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Engineered repressors are potent inhibitors of androgen receptor activity |
https://doi.org/10.18632/oncotarget.1360 Greg N. Brooke, Sue M. Powell, Derek N. Lavery, Jonathan Waxman, Laki Buluwela, Simak Ali, and Charlotte L. Bevan |
959-969 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
LZTS1 downregulation confers paclitaxel resistance and is associated with worse prognosis in breast cancer |
https://doi.org/10.18632/oncotarget.1630 Francesca Lovat, Hideshi Ishii, Monica Schiappacassi, Matteo Fassan, Mattia Barbareschi, Enzo Galligioni, Pierluigi Gasparini, Gustavo Baldassarre, Carlo M. Croce, and Andrea Vecchione |
970-977 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
WNT-pathway components as predictive markers useful for diagnosis, prevention and therapy in inflammatory bowel disease and sporadic colorectal cancer |
https://doi.org/10.18632/oncotarget.1571 Annalucia Serafino, Noemi Moroni, Manuela Zonfrillo, Federica Andreola, Luana Mercuri, Giuseppe Nicotera, Joseph Nunziata, Riccardo Ricci, Armando Antinori, Guido Rasi, and Pasquale Pierimarchi |
978-992 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Post-transcriptional regulation of MRE11 expression in muscle-invasive bladder tumours |
https://doi.org/10.18632/oncotarget.1627 Rebecca M. Martin, Martin Kerr, Mark T.W. Teo, Sarah J. Jevons, Marianne Koritzinsky, Bradly G. Wouters, Selina Bhattarai, and Anne E. Kiltie |
993-1003 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Repression of PLA2R1 by c-MYC and HIF-2alpha promotes cancer growth |
https://doi.org/10.18632/oncotarget.1681 David Vindrieux, Guillaume Devailly, Arnaud Augert, Benjamin Le Calve, Mylene Ferrand, Pascal Pigny, Lea Payen, Gerard Lambeau, Michael Perrais, Sebastien Aubert, Hélène Simonnet, Robert Dante, and David Bernard |
1004-1013 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Indirect targeting of IGF receptor signaling in vivo by substrate-selective inhibition of PAPP-A proteolytic activity |
https://doi.org/10.18632/oncotarget.1629 Jakob H. Mikkelsen, Zachary T. Resch, Bhanu Kalra, Gopal Savjani, Ajay Kumar, Cheryl A. Conover, and Claus Oxvig |
1014-1025 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
SCFβ-TRCP-mediated degradation of NEDD4 inhibits tumorigenesis through modulating the PTEN/Akt signaling pathway |
https://doi.org/10.18632/oncotarget.1675 Jia Liu, Lixin Wan, Pengda Liu, Hiroyuki Inuzuka, Jiankang Liu, Zhiwei Wang, and Wenyi Wei |
1026-1037 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Constitutive IDO expression in human cancer is sustained by an autocrine signaling loop involving IL-6, STAT3 and the AHR |
https://doi.org/10.18632/oncotarget.1637 Ulrike M. Litzenburger, Christiane A. Opitz, Felix Sahm, Katharina J. Rauschenbach, Saskia Trump, Marcus Winter, Martina Ott, Katharina Ochs, Christian Lutz, Xiangdong Liu, Natasa Anastasov, Irina Lehmann, Thomas Höfer, Andreas von Deimling, Wolfgang Wick, and Michael Platten |
1038-1051 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Hypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver gene |
https://doi.org/10.18632/oncotarget.1697 Erling A. Hoivik, Kanthida Kusonmano, Mari K. Halle, Anna Berg, Elisabeth Wik, Henrica M. J. Werner, Kjell Petersen, Anne M. Oyan, Karl-Henning Kalland, Camilla Krakstad, Jone Trovik, Martin Widschwendter, and Helga B. Salvesen |
1052-1061 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Rapamycin downregulates thymidylate synthase and potentiates the activity of pemetrexed in non-small cell lung cancer |
https://doi.org/10.18632/oncotarget.1760 Shigeru Kawabata, Chun-Te Chiang, Junji Tsurutani, Hideaki Shiga, Matthew L. Arwood, Takefumi Komiya, Joell J. Gills, Regan M. Memmott, and Phillip A. Dennis |
1062-1070 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
SENP5 mediates breast cancer invasion via a TGFβRI SUMOylation cascade |
https://doi.org/10.18632/oncotarget.1783 Rivki Cashman, Helit Cohen, Rotem Ben-Hamo, Alona Zilberberg, and Sol Efroni |
1071-1082 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
miR-17/20 sensitization of breast cancer cells to chemotherapy-induced apoptosis requires Akt1 |
https://doi.org/10.18632/oncotarget.1804 Zuoren Yu, Zengguang Xu, Gabriele DiSante, Jennifer Wright, Min Wang, Yuan Li, Qian Zhao, Tao Ren, Xiaoming Ju, Ellen Gutman, Guangxue Wang, Sankar Addya, Tieyan Li, Zhendong Xiang, Chenguang Wang, Xiongfei Yang, Xiaolai Yang, and Richard Pestell |
1083-1090 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
HCMV glycoprotein B is expressed in primary glioblastomas and enhances growth and invasiveness via PDGFR-alpha activation |
https://doi.org/10.18632/oncotarget.1787 Charles Cobbs, Sabeena Khan, Lisa Matlaf, Sean McAllister, Alex Zider, Garret Yount, Kenneth Rahlin, Lualhati Harkins, Vladimir Bezrookove, Eric Singer, and Liliana Soroceanu |
1091-1100 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Functional analysis of MKP-1 and MKP-2 in breast cancer tamoxifen sensitivity |
https://doi.org/10.18632/oncotarget.1795 Kelly K. Haagenson, Jessica Wei Zhang, Zhengfan Xu, Malathy P.V. Shekhar, and Gen Sheng Wu |
1101-1115 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Copyright © 2021 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC